Uncategorized

December 19th, 2013

A Global Push to End Alzheimer’s

by Paul Stoffels, MD, Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Janssen Pharmaceuticals

Editor’s note: Dr. Paul Stoffels recently participated in the G8 Dementia Summit in London as the only industry speaker.  He joined UK Prime Minister David Cameron and Dr. Margaret Chan, Director General of the World Health Organization (WHO) among many others to discuss and develop a coordinated global action on dementia, one of the biggest health challenges in the coming decades.  Dr. Stoffels shares his thoughts about the conference in this blog post.

Thirty years ago, the world faced the global crisis of HIV/AIDS. It was a complex disease that was little understood, spreading, and claiming the lives of people all over the world. At the time, there were no AIDS specific treatments; an HIV diagnosis meant death within 2 years. The first World AIDS Day was held in 1988 to identify solutions for working together to make a significant impact on the disease in part through research and the development of new treatments. Later, in 2002, the G8 came together to coordinate resources and efforts to improve access to new medicines through the development of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Read More

December 2nd, 2013

Celebrating Giving Tuesday

Welcome to #GivingTuesday!  Johnson & Johnson is proud to support the 92nd St Y and the United Nations Foundation in this movement to come together and give back to communities, organizations and people in need.

To celebrate giving today and throughout the holiday season, we’re proud to announce the launch of our CARE GROWS giving program, which you can visit at www.caregrows.com.  It’s simple – visit the website, make a donation through one of our three social good programs, and we’ll match it.  Select a project to fund through Catapult, donate a photo through the Johnson & Johnson Donate a Photo app, or give a gift in the Save the Children Gifts of Joy catalog – and Johnson & Johnson will match your donation.

Want to read more about Giving Tuesday?

You can follow us on Twitter or visit our Facebook page for updates throughout the day and the holiday season.

Read More

November 26th, 2013

Thanksgiving Dinner with a Mustache, Anyone?

By David Silver, Product Director at Janssen Biotech, Inc.

movember1Disruptive mustaches are an annual focal point of Thanksgiving dinners in my household.  For my wife, nothing screams “Let’s give thanks for this meal” more than looking across the table at my terrible mustache.

For the last three years, my wife and I have participated in Movember (the month formerly known as November in our house).   The goal of Movember is to literally and educationally change the face of men’s health in a fun and engaging way.  Men grow and women support a Mo (moustache) for 30 days.   Men’s “Mo’s” become walking, talking billboards to raise awareness about health programs that combat prostate and testicular cancers.

Today, one in six men in the United States will be diagnosed with prostate cancer in his lifetime making it the most frequently diagnosed cancer in men after skin cancer.  In 2013, more than 238,000 new cases of the disease will be diagnosed and almost 30,000 men will die of prostate cancer in the United States.

Despite these figures, the level of awareness, understanding and support for prostate cancer lags significantly behind that of women’s health causes.   Consider these facts, according the Movember website:

  • A man is 35% more likely to be diagnosed with prostate cancer than a woman is to be diagnosed with breast cancer.

Read More

November 12th, 2013

Johnson & Johnson and Its Partners Offer Aid to Philippines

Following the devastation of Super Typhoon Haiyan, Johnson & Johnson has been working through our partners to offer support to those affected.  Below is an excerpt of a message sent to all Johnson & Johnson employees from our Corporate Contributions team.

What has been described as one of the strongest storms in recorded history, Super Typhoon Haiyan (known as Yolanda locally), battered the central Philippine islands of Leyte and Samar on November 8 with winds of up to 235 miles per hour followed by devastating storm surges that washed away homes and lives.

We are relieved and grateful to know that all of our employees are safe, but heartbroken that so many people in the region have lost loved ones, homes and livelihoods.

Through our disaster relief partners, the Johnson & Johnson Family of Companies has already mobilized pre-positioned disaster relief supplies to help the people of the Philippines. Direct Relief International  (@DirectRelief),  AmeriCares  (@AmeriCares),  and Heart to Heart International  (@Heart_to_Heart) are moving swiftly to deliver donated medical supplies, hygiene kits and personal care products.

As the recovery begins, we will work together with our partners to determine next steps and mobilize the best possible support for the millions of people impacted by the storm. 

Read More

October 18th, 2013

Former Johnson & Johnson Corporate Vice President of Public Relations, Lawrence G. Foster, Dies at 88

The following is a personal email from Alex Gorsky, Chairman and CEO of Johnson & Johnson, sent to employees earlier today regarding the passing of Lawrence G. Foster, former Johnson & Johnson Vice President of Public Relations.

It is with great sadness that I inform you of the passing of former Johnson & Johnson Corporate Vice President of Public Relations, Lawrence G. Foster.  Larry, who is perhaps best known for guiding the company’s now famous response to the Tylenol® crises of 1982 and 1986, died yesterday at the age of 88.

Many former colleagues and friends of Larry have reached out to reflect on his significant contributions to Johnson & Johnson during his 33 years at the Company, as well as his many accomplishments and philanthropic efforts that continued after his retirement in 1990.   Ralph Larsen, former Johnson & Johnson Chairman and CEO (1989-2001), said, “Larry Foster was a man of integrity and extraordinarily good judgment.  He played a vital role during his lifetime career at Johnson & Johnson.”

Earlier today, the Foster family issued the following obituary announcement that pays fitting tribute to Larry’s remarkable career, service in the community, and contributions to the communication profession.  As we reflect on his passing today, we will best honor his important legacy by finding our own ways to manage with purpose and integrity and meet the responsibilities outlined in Our Credo.

Read More

September 18th, 2013

Continuing to Lead by Example – Johnson & Johnson Recognized for Global Cancer Prevention and Support in the Workplace

by Fik Isaac, MD, Vice President Global Health Services and Chief Medical Officer, Wellness & Prevention, Inc., a Johnson & Johnson Company

Back in 2001, Former President George H. W. Bush, the 41st President of the United States, asked a gentleman named Robert Ingram (CEO of Glaxo Wellcome at the time) to chair the CEO Roundtable on Cancer in support of an initiative known as the C-Change.  This national forum brought together key leaders from business, government and academia, who shared the common goal to eliminate cancer.  Specifically, Mr. Bush asked Mr. Ingram to form a separate organization of action-oriented chief executive officers that would “do something” about cancer prevention, diagnosis and treatment for their own families, as well as their corporate families.  And, well, the rest is history.

Today, the CEO Roundtable on Cancer is a 501(c)(3) nonprofit organization that remains committed to fulfilling Former President Bush’s challenge to be “bold and venturesome” in considering the health of employees and the war against cancer.  This rings true in each of the organization’s three key categories: risk reduction, early detection and quality care.  And more than four million employees and family members are benefiting from the vision and leadership of nearly 150 employers who’ve chosen to become Gold Standard accredited.

Read More

August 12th, 2013

Johnson & Johnson Employee Artists Recognized Through the 19th Annual Employee Art Exhibition

By Heather Cammarata-Seale, Exhibitions Coordinator, Johnson & Johnson Corporate Art Program

Every day, Johnson & Johnson supports its employees through corporate programs and initiatives that care for their health and well-being. On Thursday, August 1, we celebrated the installation of the latest exhibition of the Corporate Art Program, the 19th Annual Employee Art Exhibition, at Johnson & Johnson World Headquarters in New Brunswick. Every year this exhibition gives corporate employees and their immediate families an opportunity to showcase their creativity, ingenuity and artistry. The fine art, photography, craft, and literary pieces on display demonstrate the varied interests and abilities of Johnson & Johnson’s talented employees and families.

This art exhibition is one of 13 sponsored by the Johnson & Johnson Corporate Art Program in 2013 – six in the World Headquarters Gallery and seven in the New Jersey Artists Gallery. The Johnson & Johnson Corporate Art Program aims to educate, engage, and inspire employees and the local community by promoting philanthropy, wellness, and cultural and social awareness through permanent art installations and rotational exhibitions at our World Headquarters in New Brunswick, New Jersey. The Corporate Art Program highlights current artistic endeavors and features work of living New Jersey artists as well as artists who deal with themes related to science, healthcare, consumerism, and New Jersey culture.

Read More

July 17th, 2013

Johnson & Johnson Named to the NYSE Century Index

by Dominic Caruso, Vice President, Finance and Chief Financial Officer of Johnson & Johnson

This Wednesday I attended one of the more unique events of my career at Johnson & Johnson: a meeting of the small subset of American companies that are 100 years old or older. At the historic New York Stock Exchange, I joined leaders from a variety of companies spanning the breadth of American business, many of whose products and ideas helped shape the modern world. The sessions at the event allowed us to share stories and best practices from a wide variety of organizations that have continued to innovate and reinvent themselves as technologies, markets and the world have changed. At the close of the day’s events, I joined Con Edison’s CEO Kevin Burke and other CEOs in the Century Club to ring the closing bell for the New York Stock Exchange.

 

Over the course of the past century, social, political and economic conditions, as well as technological advances have caused companies in the Century Club to dramatically transform their businesses, and in some cases even pioneer new industries. At Johnson & Johnson, we have remained laser focused on healthcare, but have also gone through transformative periods that have helped us grow by advancing science, technology, and the care of more than a billion people around the world each day.

Read More

July 12th, 2013

The Question of Charitable Giving

by Devon Eyer, Director, Social Media, Johnson & Johnson

Michael Bzdak, Executive Director of Corporate Contributions, asked the question: “Is it better to give with your heart or with your head?” in a recent piece published by The Council on Foundations. We think you’ll find it to be a fascinating look at the two sides of giving, along with why and how both are important. You can read Michael’s perspective here.

Read More

June 24th, 2013

Why We Sponsor Good Science Writing

by Seema Kumar, Vice President, Enterprise Innovation and Global Health Communication, Johnson & Johnson

It’s simple: We need good science communicators as much as we need good science. Without reliable information—the explanation of fact, the exposure of challenges—science and the solutions it brings us could not exist. Productive inquiry would run dry. Frontiers would ebb.

Our company depends on people who can communicate hard science in lucid language, from the laboratory bench right through to those who engage directly with doctors. We depend on them to get the science right, to check sources, interpret and clarify. Their counsel helps guide our behaviour: promoting sound policies and sparking new discoveries. They bring ideas to life, inspire innovation and collaboration and encourage engagement with Science, Technology, Engineering and Medicine in a world that demands educated, informed decision makers. We, Johnson & Johnson and the public, could not effectively govern ourselves or make progress for the benefit of the doctors, nurses, patients and customers we serve otherwise.

When Dr. Paul Janssen, our pharmaceutical company’s namesake, was alive and still heading our research and development operations, he would make a daily circuit around the labs asking each researcher his celebrated catch-phrase-cum-call to action, “What’s new?” Connecting ideas (in his head) and people (in his labs), Dr.

Read More